Prior to arriving to consult on the patient she was intubated and sedated for airway protection.
Unable to obtain review of systems given patients recent intubation and no family available to dicuss.
Past Medical History: Poorly differentiated Nodular Lymphoma, >20years ago in pelvis, s/p XRT, in remission Hypertension Hyperlipidemia CKD, baseline creat 1.2-.14 Anemia, unclear etiology (extensive w/u with labs, BMB, GI w/u neg, may be [**3-11**] CKD) s/p TAH/BSO for pelvic mass/metrorrhagia '[**85**] Thyroiditis  Social History: The patient lives in [**Location 669**] with her Husband and son.
III, IV, VI: unable to assess V, VII: unable to assess VIII: unable to assess IX, X: unable to assess [**Doctor First Name 81**]: unable to assess XII: unable to assess  Motor: MAE  Sensation: unable to assess  Toes downgoing bilaterally  Coordination: unable to assess  Pertinent Results: [**10-14**] CT head noncontrast: 2-cm rounded hypodensity in the left parietooccipital region concerning for underlying intra-axial mass with edema  [**10-14**] MRI with and without contrast: 3 x 2.8 cm cystic mass with internal enhancing mural nodule  [**10-15**] CT Torso with and without contrast: Scattered enlarged and necrotic lymph nodes  [**10-15**] CTA head: Hypoattenuating left parietal lesion is redemonstrated, suspicious for neoplasm.
Post-surgical changes from left parietal craniotomy including mild frontoparietal pneumocephalus, post-operative hemorrhage and subcutaneous air.
She was continued on Dilantin for seizures.
CT torso performed for metastatic work up demonstrated multiple enlarged scattered and necrotic lymph nodes.
On [**10-16**] she remained intubated and was prepared to be taken to the OR for resection of her lesion.
She had an MRI WAND study and CTA for operative planning and was taken to the operating room for resection on the afternoon of [**10-16**].
Given she was already seen at the [**Hospital3 328**] for her prior lymphoma and her anemia, she preferred to pursue further evaluation and treatment there.
She was continued on Phenytoin and Decadron for seizure prophylaxis and instructed not to drive or return to work until seen by Dr.[**Last Name (STitle) **].
She was maintained on half of her home dose of Atenolol and her Lisinopril was held; she maintained good blood pressures on this regimen and was instructed to follow-up with her PCP for repeat blood pressure checks.
Medications on Admission: Lisinopril 20 mg po daily Omeprazole 20 mg po daily Atenolol 100 mg po bid Levothyroxine 50 mcg po daily (last filled in [**8-17**])   Discharge Medications: 1. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever/pain.
2. phenytoin 50 mg Tablet, Chewable Sig: Two (2) Tablet, Chewable PO TID (3 times a day): Please have a phenytoin level checked at your visit with Dr.[**Last Name (STitle) 724**].
Disp:*180 Tablet, Chewable(s)* Refills:*0* 3. atenolol 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): This is a lower dose than you were taking previously.
PO DAILY (Daily): Continue this medication whie you are taking Decadron (your steroid).
)(s)* Refills:*2* 5. levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
6. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours).
You underwent resection of the mass and were started on two new medications, Dilantin and Decadron, to prevent further seizures.
You will need to follow-up with a neuro-oncologist at [**Hospital3 328**] for further management of these medications and your underlying cancer.
You are being sent home on a steroid medication.
These medications can cause stomach irritation.
Make sure to take your steroid medication with meals, or a glass of milk.
Clearance to drive and return to work will be addressed at your office visit with your neuro-oncologist.
Name: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] [**Last Name (NamePattern1) **], MD Specialty: Internal Medicine When: Wednesday [**10-28**] at 9:30am Location: [**Hospital6 9657**] PHYSICIAN GROUP Address: [**Location (un) **] [**Apartment Address(1) 25389**], [**Location (un) **],[**Numeric Identifier 1700**] Phone: [**Telephone/Fax (1) 24396**]
